$OXSQ
Oxford Square Capital Corp. Stock $oxsq

$oxsq Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023035636 Filed on May 02, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$6.666M	$6.491M	$9.866M
YoY Change	-32.94%	-34.21%	5.4%
Cost Of Revenue	$5.645M	$5.475M	$4.692M
YoY Change	21.32%	16.69%	43.48%
Gross Profit	$7.868M	$7.467M	$5.174M
YoY Change	48.83%	44.31%	-15.04%
Gross Profit Margin	118.04%	115.04%	52.44%
Selling, General & Admin	$1.202M	$976.0K	$923.6K
YoY Change	27.51%	5.67%	-27.27%
% of Gross Profit	15.28%	13.07%	17.85%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$6.847M	$6.451M	$923.6K
YoY Change	626.19%	598.44%	-27.84%
Operating Profit	$1.021M	$1.016M	$4.250M
YoY Change	-76.5%	-76.1%	-11.63%
Interest Expense	$3.088M	$3.085M	-$12.45M
YoY Change	-106.46%	-124.79%	-173.35%
% of Operating Profit	302.5%	303.74%	-292.86%
Other Income/Expense, Net	$1.258M	$1.160M	$1.607M
YoY Change	-19.65%	-27.82%
Pretax Income	$11.59M	$6.268M	-$8.197M
YoY Change	-126.68%	-176.47%	-137.62%
Income Tax
% Of Pretax Income
Net Earnings	$11.59M	$6.268M	-$8.197M
YoY Change	-126.68%	-176.47%	-137.62%
Net Earnings / Revenue	173.83%	96.58%	-83.09%
Basic Earnings Per Share	$0.13	$0.13	$0.09
Diluted Earnings Per Share	$0.13	$0.13	-$164.9K
COMMON SHARES
Basic Shares Outstanding	49.90M shares	49.87M shares	49.70M shares
Diluted Shares Outstanding	50.54M shares	49.86M shares	49.70M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$43.03M	$10.76M	$15.07M
YoY Change	85.41%	-28.6%	-62.03%
Cash & Equivalents	$43.03M	$10.76M	$14.82M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$47.15M	$14.81M	$18.36M
YoY Change	78.96%	-19.31%	-55.66%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$306.1M	$319.7M	$406.2M
YoY Change	-17.13%	-21.3%	26.7%
Other Assets
YoY Change
Total Long-Term Assets	$307.1M	$320.4M	$406.8M
YoY Change	-17.08%	-21.24%	26.62%
TOTAL ASSETS
Total Short-Term Assets	$47.15M	$14.81M	$18.36M
Total Long-Term Assets	$307.1M	$320.4M	$406.8M
Total Assets	$354.3M	$335.2M	$425.2M
YoY Change	-10.7%	-21.16%	17.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.557M	$2.390M	$1.607M
YoY Change	63.37%	48.75%	14.75%
Accrued Expenses	$2.497M	$1.773M	$1.728M
YoY Change	38.89%	2.59%	32.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.054M	$4.163M	$3.335M
YoY Change	50.28%	24.83%	23.51%
LONG-TERM LIABILITIES
Long-Term Debt	$186.8M	$186.6M	$185.6M
YoY Change	0.51%	0.51%	73.47%
Other Long-Term Liabilities		$4.658M	$4.925M
YoY Change		-5.43%	-54.82%
Total Long-Term Liabilities	$186.8M	$191.2M	$190.5M
YoY Change	-11.28%	0.35%	61.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.054M	$4.163M	$3.335M
Total Long-Term Liabilities	$186.8M	$191.2M	$190.5M
Total Liabilities	$191.8M	$195.4M	$193.9M
YoY Change	-10.32%	0.78%	60.76%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$564.0K	$498.9K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$162.4M	$139.8M	$231.3M
YoY Change
Total Liabilities & Shareholders Equity	$354.3M	$335.2M	$425.2M
YoY Change	-10.7%	-21.16%	17.23%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$11.59M	$6.268M	-$8.197M
YoY Change	-126.68%	-176.47%	-137.62%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$21.28M	$6.845M	$11.15M
YoY Change	61.09%	-38.62%	-178.54%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.99M	-$5.101M	-5.094M
YoY Change	-316.41%	0.15%	-2.04%
NET CHANGE
Cash From Operating Activities	21.28M	$6.845M	11.15M
Cash From Investing Activities
Cash From Financing Activities	10.99M	-$5.101M	-5.094M
Net Change In Cash	32.27M	$1.744M	6.058M
YoY Change	296.69%	-71.21%	-131.23%
FREE CASH FLOW
Cash From Operating Activities	$21.28M	$6.845M	$11.15M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	420800000	usd
CY2022	oxsq	Net Realized Gains Losses Included In Earnings NetRealizedGainsLossesIncludedInEarnings	-300000	usd
CY2022	oxsq	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Appreciation Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedAppreciationIncludedInEarnings	-105900000	usd
CY2022	oxsq	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Accretion Of Discount FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscount	900000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	84200000	usd
CY2023Q1	us-gaap	Assets Assets	335216919	usd
CY2022Q4	us-gaap	Assets Assets	327994435	usd
CY2023Q1	us-gaap	Securities Loaned SecuritiesLoaned	4657500	usd
CY2023Q1	oxsq	Base Fee And Net Investment Income Incentive Fee Payable To Affiliate BaseFeeAndNetInvestmentIncomeIncentiveFeePayableToAffiliate	2389630	usd
CY2022Q4	oxsq	Base Fee And Net Investment Income Incentive Fee Payable To Affiliate BaseFeeAndNetInvestmentIncomeIncentiveFeePayableToAffiliate	1323573	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1216109	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1216109	usd
CY2023Q1	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	557122	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	458001	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-64600000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	195377771	usd
CY2022	oxsq	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Reduction Equity Cost Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetReductionEquityCostValue	-20400000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	314700000	usd
CY2022	oxsq	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Depreciation FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedDepreciation	-105200000	usd
CY2022Q4	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Percent Equity Securities FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePercentEquitySecurities	1	pure
CY2022Q4	us-gaap	Liabilities Liabilities	189322473	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	814-00638
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	OXFORD SQUARE CAPITAL CORP.
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-0188736
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	8 SOUND SHORE DRIVE
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	SUITE 255
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	GREENWICH
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06830
CY2023Q1	dei	City Area Code CityAreaCode	(203)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	983-5275
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49901171	shares
CY2023Q1	oxsq	Nonaffiliated Investments Owned At Cost NonaffiliatedInvestmentsOwnedAtCost	495000997	usd
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	314599117	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	310347097	usd
CY2023Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	16836822	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	16836822	usd
CY2023Q1	oxsq	Affiliated Investmentscost AffiliatedInvestmentscost	5070307	usd
CY2022Q4	oxsq	Affiliated Investmentscost AffiliatedInvestmentscost	4349818	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10763167	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9019164	usd
CY2023Q1	us-gaap	Interest Receivable InterestReceivable	4047953	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	3492716	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	736375	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	785640	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	oxsq	Nonaffiliated Investments Owned At Cost NonaffiliatedInvestmentsOwnedAtCost	495212632	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Securities Loaned SecuritiesLoaned		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49844796	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49844796	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	498859	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	498447	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	434871321	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	434737950	usd
CY2023Q1	oxsq	Total Distributable Earningsaccumulated Losses TotalDistributableEarningsaccumulatedLosses	-295531032	usd
CY2022Q4	oxsq	Total Distributable Earningsaccumulated Losses TotalDistributableEarningsaccumulatedLosses	-296564435	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	139839148	usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49690059	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49690059	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	138671962	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	335216919	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	327994435	usd
CY2023Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.8
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.78
CY2023Q1	us-gaap	Interest Income Debt Securities Operating InterestIncomeDebtSecuritiesOperating	8294160	usd
CY2022Q1	us-gaap	Interest Income Debt Securities Operating InterestIncomeDebtSecuritiesOperating	5250149	usd
CY2023Q1	oxsq	Income From Securitization Vehicles And Investments IncomeFromSecuritizationVehiclesAndInvestments	4379495	usd
CY2022Q1	oxsq	Income From Securitization Vehicles And Investments IncomeFromSecuritizationVehiclesAndInvestments	4441195	usd
CY2023Q1	us-gaap	Other Income OtherIncome	268143	usd
CY2022Q1	us-gaap	Other Income OtherIncome	174526	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	12941798	usd
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	9865870	usd
CY2023Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	12941798	usd
CY2022Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	9865870	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	3085366	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	3085366	usd
CY2023Q1	us-gaap	Other Expenses OtherExpenses	1159646	usd
CY2022Q1	us-gaap	Other Expenses OtherExpenses	1606503	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	335880	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	344522	usd
CY2023Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	266965	usd
CY2022Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	235003	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	373173	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	344102	usd
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	5221030	usd
CY2022Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	5615496	usd
CY2023Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1229984	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	6451014	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	5615496	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	6490784	usd
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	4250374	usd
CY2023Q1	oxsq	Unrealized Depreciation Appreciation On Non Affiliate Non Control Investments UnrealizedDepreciationAppreciationOnNonAffiliateNonControlInvestments	942790	usd
CY2022Q1	oxsq	Unrealized Depreciation Appreciation On Non Affiliate Non Control Investments UnrealizedDepreciationAppreciationOnNonAffiliateNonControlInvestments	13690696	usd
CY2023Q1	oxsq	Affiliates Investments Unrecognized Unrealized Appreciation Depreciation Net AffiliatesInvestmentsUnrecognizedUnrealizedAppreciationDepreciationNet	-720489	usd
CY2022Q1	oxsq	Affiliates Investments Unrecognized Unrealized Appreciation Depreciation Net AffiliatesInvestmentsUnrecognizedUnrealizedAppreciationDepreciationNet	-200847	usd
CY2023Q1	oxsq	Total Net Change In Unrealized Depreciation On Investments TotalNetChangeInUnrealizedDepreciationOnInvestments	-222301	usd
CY2022Q1	oxsq	Total Net Change In Unrealized Depreciation On Investments TotalNetChangeInUnrealizedDepreciationOnInvestments	-13489849	usd
CY2022Q1	oxsq	Nonaffiliatednoncontrol Investments NonaffiliatednoncontrolInvestments	-1042286	usd
CY2022Q1	oxsq	Total Net Realized Gains TotalNetRealizedGains	1042286	usd
CY2023Q1	oxsq	Net Increasedecrease In Net Assets Resulting From Operations Amounts NetIncreasedecreaseInNetAssetsResultingFromOperationsAmounts	6268483	usd
CY2022Q1	oxsq	Net Increasedecrease In Net Assets Resulting From Operations Amounts NetIncreasedecreaseInNetAssetsResultingFromOperationsAmounts	-8197189	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2023Q1	oxsq	Net Increasedecrease In Net Assets Basic NetIncreasedecreaseInNetAssetsBasic	0.13
CY2022Q1	oxsq	Net Increasedecrease In Net Assets Basic NetIncreasedecreaseInNetAssetsBasic	-0.16
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49858366	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49700764	shares
CY2023Q1	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.105
CY2022Q1	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.105
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	6490784	usd
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	4250374	usd
CY2023Q1	oxsq	Net Change In Unrealized Depreciation On Investments NetChangeInUnrealizedDepreciationOnInvestments	-222301	usd
CY2022Q1	oxsq	Net Change In Unrealized Depreciation On Investments NetChangeInUnrealizedDepreciationOnInvestments	-13489849	usd
CY2022Q1	oxsq	Net Realized Gains NetRealizedGains	1042286	usd
CY2023Q1	oxsq	Net Increasedecrease In Net Assets Resulting From Operations Amount NetIncreasedecreaseInNetAssetsResultingFromOperationsAmount	6268483	usd
CY2022Q1	oxsq	Net Increasedecrease In Net Assets Resulting From Operations Amount NetIncreasedecreaseInNetAssetsResultingFromOperationsAmount	-8197189	usd
CY2023Q1	oxsq	Distributions From Net Investment Income DistributionsFromNetInvestmentIncome	-5235080	usd
CY2022Q1	oxsq	Distributions From Net Investment Income DistributionsFromNetInvestmentIncome	-4227020	usd
CY2022Q1	us-gaap	Investment Company Tax Return Of Capital Distribution InvestmentCompanyTaxReturnOfCapitalDistribution	-991523	usd
CY2023Q1	oxsq	Total Distributions To Stockholders Amount TotalDistributionsToStockholdersAmount	-5235080	usd
CY2022Q1	oxsq	Total Distributions To Stockholders Amount TotalDistributionsToStockholdersAmount	-5218543	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	133783	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	124734	usd
CY2023Q1	oxsq	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	133783	usd
CY2022Q1	oxsq	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	124734	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1167186	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-13290998	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	138671962	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	244595125	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	139839148	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	231304127	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	41158	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	31583	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	41158	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	31583	shares
CY2023Q1	oxsq	Net Increasedecrease In Net Assets Resulting NetIncreasedecreaseInNetAssetsResulting	6268483	usd
CY2022Q1	oxsq	Net Increasedecrease In Net Assets Resulting NetIncreasedecreaseInNetAssetsResulting	-8197189	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	340019	usd
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	253267	usd
CY2023Q1	oxsq	Accretion Of Discount On Notes Payable And Deferred Debt Issuance Costs AccretionOfDiscountOnNotesPayableAndDeferredDebtIssuanceCosts	232621	usd
CY2022Q1	oxsq	Accretion Of Discount On Notes Payable And Deferred Debt Issuance Costs AccretionOfDiscountOnNotesPayableAndDeferredDebtIssuanceCosts	232621	usd
CY2023Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	3525000	usd
CY2022Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	42426136	usd
CY2023Q1	oxsq	Repayment Of Principal Securities Investments RepaymentOfPrincipalSecuritiesInvestments	318680	usd
CY2022Q1	oxsq	Repayment Of Principal Securities Investments RepaymentOfPrincipalSecuritiesInvestments	38612386	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	3375000	usd
CY2022Q1	oxsq	Realized Investment Gain Losses RealizedInvestmentGainLosses	1042286	usd
CY2023Q1	oxsq	Reductions To Clo Equity Cost Value ReductionsToCLOEquityCostValue	3009028	usd
CY2022Q1	oxsq	Reductions To Clo Equity Cost Value ReductionsToCLOEquityCostValue	7786589	usd
CY2023Q1	oxsq	Net Change In Unrealized Appreciationdepreciation On Investments NetChangeInUnrealizedAppreciationdepreciationOnInvestments	222301	usd
CY2022Q1	oxsq	Net Change In Unrealized Appreciationdepreciation On Investments NetChangeInUnrealizedAppreciationdepreciationOnInvestments	13489849	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	555237	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	217158	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-49265	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	13358	usd
CY2023Q1	oxsq	Increase Decrease In Base Fee And Net Investment Income Incentive Fee Payable IncreaseDecreaseInBaseFeeAndNetInvestmentIncomeIncentiveFeePayable	-1066057	usd
CY2022Q1	oxsq	Increase Decrease In Base Fee And Net Investment Income Incentive Fee Payable IncreaseDecreaseInBaseFeeAndNetInvestmentIncomeIncentiveFeePayable	82209	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	99121	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-112872	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6845300	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11151970	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	133783	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	124734	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5101297	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5093809	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5101297	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5093809	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1744003	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6058161	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9019164	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9015700	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10763167	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15073861	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	133783	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	124734	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	2852747	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	2852747	usd
CY2023Q1	oxsq	Securities Purchase Not Settled SecuritiesPurchaseNotSettled	4657500	usd
CY2022Q1	oxsq	Securities Purchase Not Settled SecuritiesPurchaseNotSettled	4925000	usd
CY2022	oxsq	Cost Basis Amortization Of Fee Letter Investments CostBasisAmortizationOfFeeLetterInvestments	128000	usd
CY2023Q1	us-gaap	Other Investments And Securities At Cost OtherInvestmentsAndSecuritiesAtCost	319700000	usd
CY2023Q1	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Percent Equity Securities FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePercentEquitySecurities	1	pure
CY2022Q4	us-gaap	Other Investments And Securities At Cost OtherInvestmentsAndSecuritiesAtCost	314700000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">USE OF ESTIMATES</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The financial statements have been prepared in accordance with GAAP, which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from those estimates, and these differences could be material.</p>
CY2023Q1	oxsq	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Accretion Of Discount FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscount	300000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	8200000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-300000	usd
CY2023Q1	oxsq	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Reduction Equity Cost Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetReductionEquityCostValue	-3000000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	319700000	usd
CY2023Q1	oxsq	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Depreciation FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedDepreciation	-200000	usd
CY2023Q1	oxsq	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Reductions Equity Cost Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetReductionsEquityCostValue	3000000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	7300000	usd
CY2023Q1	oxsq	Cost Basis Amortization Of Fee Letter Investments CostBasisAmortizationOfFeeLetterInvestments	52000	usd
CY2023Q1	oxsq	Income From Securitization Vehicles And Investment IncomeFromSecuritizationVehiclesAndInvestment	4400000	usd
CY2023Q1	oxsq	Distribution Of Investment Percentage DistributionOfInvestmentPercentage	0.90	pure
CY2023Q1	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	544670402	usd
CY2022Q4	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	536518866	usd
CY2023Q1	us-gaap	Senior Notes SeniorNotes	218700000	usd
CY2023Q1	oxsq	Clo Equity CloEquity	95900000	usd
CY2023Q1	oxsq	Equity And Other Investments EquityAndOtherInvestments	5100000	usd
CY2023Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	319700000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	10500000	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	330200000	usd
CY2022Q4	us-gaap	Senior Notes SeniorNotes	211400000	usd
CY2022Q4	oxsq	Clo Equity CloEquity	98900000	usd
CY2022Q4	oxsq	Equity And Other Investments EquityAndOtherInvestments	4300000	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	314700000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	7300000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	322000000	usd
CY2023Q1	oxsq	Investments Fair Value Disclosure1 InvestmentsFairValueDisclosure1	319700000	usd
CY2022Q4	oxsq	Investments Fair Value Disclosure1 InvestmentsFairValueDisclosure1	314700000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	314700000	usd
CY2023Q1	oxsq	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Appreciation Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedAppreciationIncludedInEarnings	-200000	usd
CY2023Q1	us-gaap	Cash Cash	252385	usd
CY2022Q4	us-gaap	Cash Cash	1673650	usd
CY2023Q1	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	10510782	usd
CY2022Q4	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	7345514	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	10763167	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	9019164	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	In accordance with the 1940 Act, with certain limited exceptions, the Company is only allowed to borrow amounts such that its asset coverage, as defined in the 1940 Act, is at least 150%, immediately after such borrowing.
CY2023Q1	oxsq	Asset Coverage Percentage AssetCoveragePercentage	1.72	pure
CY2022Q4	oxsq	Asset Coverage Percentage AssetCoveragePercentage	1.71	pure
CY2023Q1	us-gaap	Debt Instrument Description Of Variable Rate Basis DebtInstrumentDescriptionOfVariableRateBasis	The weighted average stated interest rate and weighted average maturity on the Company’s borrowings as of March 31, 2023 were 6.02% and 3.3 years, respectively, and as of December 31, 2022 were 6.02% and 3.6 years, respectively.
CY2023Q1	oxsq	Annual Hurdle Rate AnnualHurdleRate	0.0899	pure
CY2023Q1	oxsq	Preferred Return Amount Percentage PreferredReturnAmountPercentage	0.0175	pure
CY2023Q1	oxsq	Pre Incentive Fee Net Investment Income Maximum Percentage PreIncentiveFeeNetInvestmentIncomeMaximumPercentage	1	pure
CY2023Q1	oxsq	Catchup Amount Percentage CatchupAmountPercentage	0.021875	pure
CY2023Q1	us-gaap	Increase Decrease In Management And Incentive Fees Payable IncreaseDecreaseInManagementAndIncentiveFeesPayable	1229984	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	6490784	usd
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	4250374	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49858366	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49700764	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2023Q1	oxsq	Net Increasedecrease In Net Assets Resulting From Operations NetIncreasedecreaseInNetAssetsResultingFromOperations	6268483	usd
CY2022Q1	oxsq	Net Increasedecrease In Net Assets Resulting From Operations NetIncreasedecreaseInNetAssetsResultingFromOperations	-8197189	usd
CY2023Q1	oxsq	Net Increasedecrease In Net Assets Basic NetIncreasedecreaseInNetAssetsBasic	0.13
CY2022Q1	oxsq	Net Increasedecrease In Net Assets Basic NetIncreasedecreaseInNetAssetsBasic	-0.16
CY2023Q1	oxsq	Percentage Of Distribute Minimum Annual Investment Company Taxable Income PercentageOfDistributeMinimumAnnualInvestmentCompanyTaxableIncome	0.90	pure
CY2023Q1	oxsq	Percentage Of Investment Company Excise Tax PercentageOfInvestmentCompanyExciseTax	0.04	pure
CY2023Q1	us-gaap	Interest And Dividends Payable Current And Noncurrent InterestAndDividendsPayableCurrentAndNoncurrent	1700000	usd
CY2023Q1	us-gaap	Interest And Dividends Payable Current And Noncurrent InterestAndDividendsPayableCurrentAndNoncurrent	1700000	usd
CY2023Q1	us-gaap	Interest And Dividends Payable Current And Noncurrent InterestAndDividendsPayableCurrentAndNoncurrent	1700000	usd
CY2023Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.035
CY2023Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.035
CY2023Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.035
CY2023Q1	us-gaap	Partners Capital Distribution Amount Per Share PartnersCapitalDistributionAmountPerShare	0.105
CY2023Q1	oxsq	Net Asset Value Per Share1 NetAssetValuePerShare1	2.8
CY2022Q4	oxsq	Net Asset Value Per Share1 NetAssetValuePerShare1	2.78
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	7945032	usd
CY2022Q1	us-gaap	Interest Income Other InterestIncomeOther	4786723	usd
CY2023Q1	oxsq	Original Issue Discount And Market Discount Income OriginalIssueDiscountAndMarketDiscountIncome	340019	usd
CY2022Q1	oxsq	Original Issue Discount And Market Discount Income OriginalIssueDiscountAndMarketDiscountIncome	253267	usd
CY2023Q1	oxsq	Discount Income Derived From Unscheduled Remittances At Par DiscountIncomeDerivedFromUnscheduledRemittancesAtPar	9109	usd
CY2022Q1	oxsq	Discount Income Derived From Unscheduled Remittances At Par DiscountIncomeDerivedFromUnscheduledRemittancesAtPar	210159	usd
CY2023Q1	oxsq	Total Interest Income TotalInterestIncome	8294160	usd
CY2022Q1	oxsq	Total Interest Income TotalInterestIncome	5250149	usd
CY2023Q1	oxsq	Income From Securitization Vehicles And Investments IncomeFromSecuritizationVehiclesAndInvestments	4379495	usd
CY2022Q1	oxsq	Income From Securitization Vehicles And Investments IncomeFromSecuritizationVehiclesAndInvestments	4441195	usd
CY2023Q1	oxsq	Fee Letters FeeLetters	155078	usd
CY2022Q1	oxsq	Fee Letters FeeLetters	166625	usd
CY2023Q1	us-gaap	Payments For Fees PaymentsForFees	113065	usd
CY2022Q1	us-gaap	Payments For Fees PaymentsForFees	7901	usd
CY2023Q1	us-gaap	Other Income OtherIncome	268143	usd
CY2022Q1	us-gaap	Other Income OtherIncome	174526	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	12941798	usd
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	9865870	usd
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.78
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	4.92
CY2023Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.13
CY2022Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.09
CY2023Q1	oxsq	Investment Company Investments Income Loss Per Share InvestmentCompanyInvestmentsIncomeLossPerShare	0
CY2022Q1	oxsq	Investment Company Investments Income Loss Per Share InvestmentCompanyInvestmentsIncomeLossPerShare	-0.25
CY2023Q1	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	0.13
CY2022Q1	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	-0.16
CY2023Q1	oxsq	Investment Company Distributions Per Share From Net Investment Income InvestmentCompanyDistributionsPerShareFromNetInvestmentIncome	-0.11
CY2022Q1	oxsq	Investment Company Distributions Per Share From Net Investment Income InvestmentCompanyDistributionsPerShareFromNetInvestmentIncome	-0.09
CY2022Q1	us-gaap	Investment Company Tax Return Of Capital Distribution Per Share InvestmentCompanyTaxReturnOfCapitalDistributionPerShare	-0.02
CY2023Q1	oxsq	Investment Company Distribution Per Share InvestmentCompanyDistributionPerShare	-0.11
CY2022Q1	oxsq	Investment Company Distribution Per Share InvestmentCompanyDistributionPerShare	-0.11
CY2023Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.8
CY2022Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	4.65
CY2023Q1	oxsq	Per Share Market Value At Beginning Of Periods PerShareMarketValueAtBeginningOfPeriods	3.12
CY2022Q1	oxsq	Per Share Market Value At Beginning Of Periods PerShareMarketValueAtBeginningOfPeriods	4.08
CY2023Q1	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	3.16
CY2022Q1	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	4.19
CY2023Q1	us-gaap	Investment Company Total Return Market Value InvestmentCompanyTotalReturnMarketValue	0.0442	pure
CY2022Q1	us-gaap	Investment Company Total Return Market Value InvestmentCompanyTotalReturnMarketValue	0.0531	pure
CY2023Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.045	pure
CY2022Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.0335	pure
CY2023Q1	us-gaap	Shares Outstanding SharesOutstanding	49885954	shares
CY2022Q1	us-gaap	Shares Outstanding SharesOutstanding	49721642	shares
CY2023Q1	us-gaap	Assets Net AssetsNet	139839	usd
CY2022Q1	us-gaap	Assets Net AssetsNet	231304	usd
CY2023Q1	oxsq	Average Net Asset AverageNetAsset	139235	usd
CY2022Q1	oxsq	Average Net Asset AverageNetAsset	237950	usd
CY2023Q1	oxsq	Ratio Of Expenses To Average Net Assets RatioOfExpensesToAverageNetAssets	0.1853	pure
CY2022Q1	oxsq	Ratio Of Expenses To Average Net Assets RatioOfExpensesToAverageNetAssets	0.0944	pure
CY2023Q1	oxsq	Ratio Of Net Investment Income To Average Net Assets RatioOfNetInvestmentIncomeToAverageNetAssets	0.1865	pure
CY2022Q1	oxsq	Ratio Of Net Investment Income To Average Net Assets RatioOfNetInvestmentIncomeToAverageNetAssets	0.0714	pure
CY2023Q1	oxsq	Portfolio Turnover Rate PortfolioTurnoverRate	0.001	pure
CY2022Q1	oxsq	Portfolio Turnover Rate PortfolioTurnoverRate	0.1009	pure
CY2022Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2023Q1	oxsq	Nonaffiliatednoncontrol Investments NonaffiliatednoncontrolInvestments		usd
CY2023Q1	oxsq	Total Net Realized Gains TotalNetRealizedGains		usd
CY2023Q1	oxsq	Operating Expenses Before Incentive Fees OperatingExpensesBeforeIncentiveFees	0.15	pure
CY2022Q1	oxsq	Operating Expenses Before Incentive Fees OperatingExpensesBeforeIncentiveFees	0.0944	pure
CY2023Q1	us-gaap	Investment Company Total Return After Incentive Fees InvestmentCompanyTotalReturnAfterIncentiveFees	0.0353	pure
CY2023Q1	oxsq	Ratio Of Expenses Excluding Interest Expense To Average Net Assets RatioOfExpensesExcludingInterestExpenseToAverageNetAssets	0.0967	pure
CY2022Q1	oxsq	Ratio Of Expenses Excluding Interest Expense To Average Net Assets RatioOfExpensesExcludingInterestExpenseToAverageNetAssets	0.0425	pure
CY2023Q1	oxsq	Netincreasedecreaseinnetassetsresultingfromoperationspercommonsharediluted Netincreasedecreaseinnetassetsresultingfromoperationspercommonsharediluted	0.13
CY2022Q1	oxsq	Netincreasedecreaseinnetassetsresultingfromoperationspercommonsharediluted Netincreasedecreaseinnetassetsresultingfromoperationspercommonsharediluted	-0.16
CY2023Q1	oxsq	Net Realized Gains NetRealizedGains		usd
CY2023Q1	us-gaap	Investment Company Tax Return Of Capital Distribution InvestmentCompanyTaxReturnOfCapitalDistribution		usd
CY2023Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		usd
CY2023Q1	oxsq	Realized Investment Gain Losses RealizedInvestmentGainLosses		usd
CY2023Q1	oxsq	Net Realized Gains Losses Included In Earnings NetRealizedGainsLossesIncludedInEarnings		usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet		usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet		usd
CY2023Q1	oxsq	Loan Prepayment And Bond Call Fees LoanPrepaymentAndBondCallFees		usd
CY2022Q1	oxsq	Loan Prepayment And Bond Call Fees LoanPrepaymentAndBondCallFees		usd
CY2023Q1	us-gaap	Investment Company Tax Return Of Capital Distribution Per Share InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
CY2023Q1	us-gaap	Investment Company Redemption Fee Per Share InvestmentCompanyRedemptionFeePerShare
CY2022Q1	us-gaap	Investment Company Redemption Fee Per Share InvestmentCompanyRedemptionFeePerShare
CY2022Q1	us-gaap	Investment Company Total Return After Incentive Fees InvestmentCompanyTotalReturnAfterIncentiveFees		pure
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001259429

Files In Submission

Name	View Source	Status
oxsq-20230331_cal.xml	Edgar Link	unprocessable
0001213900-23-035636-index-headers.html	Edgar Link	pending
0001213900-23-035636-index.html	Edgar Link	pending
0001213900-23-035636.txt	Edgar Link	pending
0001213900-23-035636-xbrl.zip	Edgar Link	pending
ea153297_10q.htm	Edgar Link	pending
ea153297_10q_htm.xml	Edgar Link	completed
ea153297_ex31-1.htm	Edgar Link	pending
ea153297_ex31-2.htm	Edgar Link	pending
ea153297_ex32-1.htm	Edgar Link	pending
ea153297_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
oxsq-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
oxsq-20230331_pre.xml	Edgar Link	unprocessable
oxsq-20230331_def.xml	Edgar Link	unprocessable
oxsq-20230331_lab.xml	Edgar Link	unprocessable
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OXSQ
Oxford Square Capital Corp. Stock $oxsq

2023 Q2 Form 10-Q Financial Statement

#000121390023035636 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OXSQ Oxford Square Capital Corp. Stock $oxsq

2023 Q2 Form 10-Q Financial Statement

#000121390023035636 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OXSQ
Oxford Square Capital Corp. Stock $oxsq